Meeting
2021 ASCO Annual Meeting
Clinical impact of pathogenic germline variants in pancreatic cancer: Results from a multicenter prospective universal genetic testing study.
Authors
Pedro Luiz Serrano Uson Junior
Mayo Clinic, Phoenix, Brazil
Pedro Luiz Serrano Uson Junior , Douglas Riegert-Johnson , Lisa A. Boardman , Mitesh J. Borad , Daniel H. Ahn , Mohamad Bassam Sonbol , Douglas O Faigel , Norio Fukami , Rahul Pannala , Katie Kunze , Michael A Golafshar , Edward D. Esplin , Robert Luke Nussbaum , Tanios S. Bekaii-Saab , Jewel Samadder
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4118)
DOI
10.1200/JCO.2021.39.15_suppl.4118
Abstract #
4118
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
The impact of homologous recombination repair (HRR) gene mutation status on treatment (tx) patterns and clinical outcomes among patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the United States (US).
First Author: Pedro C. Barata
Poster
2017 Genitourinary Cancers Symposium
Inherited pathologic mutations and family history in patients with prostate cancer.
First Author: Shuwen Lin
Poster
2023 ASCO Annual Meeting
Targeting germline or somatic DNA repair defects (beyond BRCA) in pancreatic cancer with niraparib: A phase II study (NIRA-PANC).
First Author: Anup Kasi
Poster
2023 ASCO Annual Meeting
Women with pathogenic variants in moderate penetrance breast cancer genes: How frequently do they meet high penetrance genetic testing criteria?
First Author: Nicole Casasanta